Miriam Merad's 20-Year Journey Transforms Cancer Immunotherapy

Miriam Merad's 20-year research on macrophages, immune cells involved in inflammation and immune response, is challenging traditional cancer treatments focused on T cells, and early clinical data suggest that targeting macrophages could enhance immunotherapy effectiveness and address aging and autoimmune diseases.